| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 120 | $51.75 | $6,210.00 | View Details Filing |
| Mar 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | J | 12,500 | - | - | View Details Filing |
| Mar 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | J | 12,500 | - | - | View Details Filing |
| Mar 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 24,138 | $50.09 | $1,209,072.42 | View Details Filing |
| Mar 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 10,742 | $51.00 | $547,842.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 38,640 | $0.00 | $0.00 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | F | 16,574 | $54.73 | $907,095.02 | View Details Filing |
| Mar 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 38,640 | $0.00 | $0.00 | View Details Filing |
| Feb 28, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 38,640 | $0.00 | $0.00 | View Details Filing |
| Feb 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 341,610 | $0.00 | $0.00 | View Details Filing |